Han P, Li F, Cao P, Hu S, Kong K, Deng Y, Zu Y, Zhao B. A case report with COVID-19 during perioperative period of lobectomy.
Medicine (Baltimore) 2020;
99:e20166. [PMID:
32481381 DOI:
10.1097/md.0000000000020166]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
RATIONALE
Currently, COVID-19 has made a significant impact on many countries in the world. However, there have been no reported cases of pulmonary lobectomy with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) infection. We are the first to report such a case.
PATIENT CONCERNS
We report a 63-year-old Wuhan male patient with smoking history of 40 cigarettes per day for 40 years. He sought medical consultation for right lower lung nodules found by CT scan.
DIAGNOSES AND INTERVENTIONS
The patient's postoperative pathological diagnosis was squamous cell carcinoma of the right lower lung. On the fourth day after the operation, the real-time reverse transcription polymerase chain reaction test showed a positive result. After the operation, we routinely give symptomatic treatments such as anti-infection, nebulization and oxygen inhalation. We also change antibiotics several times depending on the patient's condition.
OUTCOMES
The patient's condition continued to deteriorate. On the fifth day after surgery, the patient died despite medical treatment.
LESSONS
We are the first to report the diagnosis and treatment process of patients with COVID-19 during perioperative period of lobectomy. It provides a case for the postoperative management of such patients.
Collapse